Potassium Intake, Bioavailability, Hypertension, and Glucose Control.
Stone MS, Martyn L, Weaver CM.
Nutrients. 2016 Jul 22;8(7):444. doi: 10.3390/nu8070444.
Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial.
Chiasson JL.
Endocr Pract. 2006 Jan-Feb;12 Suppl 1:25-30. doi: 10.4158/EP.12.S1.25.
Impaired Fasting Glucose (IFG) Prevalence Among Hypolipidemic Treatment- naive Patients with Hypertension.
Papadakis J, Ioannou P, Vrentzos G, Theodorakopoulou V, Papanikolaou K, Filippatos T.
Curr Hypertens Rev. 2022;18(2):153-157. doi: 10.2174/1573402118666220321121421.
Impaired Glucose Tolerance in Primary Aldosteronism: Mechanism(s) and Clinical Implications.
Kotchen TA.
Hypertension. 2020 May;75(5):1159-1160. doi: 10.1161/HYPERTENSIONAHA.120.14765. Epub 2020 Mar 16.
Impaired glucose tolerance and albuminuria in patients with chronic heart failure: a subanalysis of the SUPPORT trial.
Nochioka K, Sakata Y, Miura M, Shiroto T, Takahashi J, Saga C, Ikeno Y, Shiba N, Shinozaki T, Sugi M, Nakagawa M, Komaru T, Kato A, Nozaki E, Iwabuchi K, Hiramoto T, Inoue K, Ohe M, Tamaki K, Tsuji I, Shimokawa H.
ESC Heart Fail. 2019 Dec;6(6):1252-1261. doi: 10.1002/ehf2.12516. Epub 2019 Oct 24.
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
Unwin N, Shaw J, Zimmet P, Alberti KG.
Diabet Med. 2002 Sep;19(9):708-23. doi: 10.1046/j.1464-5491.2002.00835.x.
Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: a community cohort study.
Lee CJ, Lim NK, Kim HC, Ihm SH, Lee HY, Park HY, Park S.
Am J Hypertens. 2015 Apr;28(4):493-500. doi: 10.1093/ajh/hpu186. Epub 2014 Sep 29.
Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
Petersen JL, McGuire DK.
Diab Vasc Dis Res. 2005 Feb;2(1):9-15. doi: 10.3132/dvdr.2005.007.
The association of impaired gestational glucose tolerance with maternal and fetal outcomes.
Kasap E, Genc M, Turan GA, Eskicioglu F, Saklamaz A, Sahin N, Guclu S.
Clin Exp Obstet Gynecol. 2016;43(5):755-758.
Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders.
Shimada K, Miyauchi K, Daida H.
Expert Rev Cardiovasc Ther. 2015 Jan;13(1):23-31. doi: 10.1586/14779072.2015.986464. Epub 2014 Dec 1.
